OAKVILLE, Ontario – November 9, 2015 – Takeda Canada is pleased to announce that Chatrick Paul has been named the new General Manager and will take on leadership of the Canadian operations of Japan’s largest pharmaceutical company.
With more than 18 years of pharmaceutical industry experience across different countries and disease areas, Mr. Paul joins Takeda Canada from Takeda Oncology, based in Boston, Massachusetts, where he was formally the Vice President of Global Marketing. During his tenure with the Oncology Business Unit, Mr. Paul’s leadership was instrumental in making great progress in planning and driving global commercialization of Takeda’s developing portfolio of cancer treatments.
“We are confident that Chatrick’s robust background will bring continued success to Takada Canada and that his leadership will help further guide the organization toward our global ambition of becoming a leading specialty care provider with a strong oncology and gastroenterology portfolio,” said Marc Princen, President of the Europe and Canada Business Unit. “I am enthusiastic about the possibilities that lie ahead for Takeda Canada under this new direction.”
Mr. Paul has been with Takeda since 2009, during which time he held various senior marketing positions. Prior to that he held other pharmaceutical marketing positions with Sanofi-Aventis and Rhone-Poulenc Rorer in the Asia-Pacific region.
About Takeda Canada
Takeda Canada, located in Oakville, Ontario, is the Canadian sales and marketing organization of Takeda Pharmaceutical Company Limited, Osaka, Japan. The company has a commercial presence covering more than 70 countries, with particular strength in Asia, North America, Europe and fast-growing emerging markets including Latin America, Russia-CIS and China. Areas of focus include cardiovascular and metabolic, oncology, respiratory and immunology, central nervous system, general medicine, and vaccines. Takeda is a research-based global company with its main focus on pharmaceuticals.
As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Through strategic acquisitions, Takeda has been transforming itself, broadening its therapeutic expertise and geographic outreach.